[201 Pages Report] Urology Surgical Instruments Market report categorizes the global market by Application (Benign Prostatic Hyperplasia, Chronic Kidney Diseases, Oncology), Product (Endoscopes, Peripheral Instruments, Endovision Systems, Consumables and Accessories) & Geography.

The global urology surgical instruments market is expected to reach USD 11.48 Billion by 2021 from USD 7.74 Billion in 2016, growing at a CAGR of 8.2% from 2016 to 2021.

The growth of the overall urology surgical instruments market can be contributed to rising prevalence of kidney diseases and urinary tract infections; rising number of hospitals and growing hospital investments in surgical infrastructure; availability of investments, funds, and grants from government bodies; and rising geriatric population.

In this report, the urology surgical instruments market has been segmented on the basis of product, and application. On the basis of product, the urology surgical instruments market is categorized into urology endoscopes, endovision systems, peripheral instruments, and consumables and accessories. The consumables and accessories segment is expected to account for the largest share of the urology surgical instruments market in 2016.

Early buyers will receive 10% customization on reports.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=120080018

Scope of the Report:
This research report categorizes the urology surgical instruments market into the following segments:

Urology Surgical Instruments Market, by Product:
• Urology Endoscopes
• Endovision Systems
• Peripheral Systems
• Consumables and Accessories

Urology Surgical Instruments Market, by Application
• Chronic Kidney Disease
• Urinary Stones
• Benign Prostatic Hyperplasia
• Urinary Incontinence and Pelvic Organ Prolapse
• Oncology

Urology Surgical Instruments Market, by Region

Request a Sample Report: http://www.marketsandmarkets.com/requestsample.asp?id=120080018

Major players in the urology surgical instruments market include Olympus Corporation (Japan), KARL STORZ GmbH & Co. KG (Germany), Richard WOLF GmbH (Germany), Coloplast A/S (Denmark), Cook Medical Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Teleflex incorporated (U.S.), Stryker Corporation (U.S.), CooperSurgical, Inc. (U.S.), and ConMed Corporation (U.S.).